The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

A new mandatory federal model aims to reduce the kidney transplant shortage by giving incentives for greater donor kidney ...

(HealthDay News) — Long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, according to a study ...

(HealthDay News) — American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare, a new study finds. They are also more ...

Prior authorization requirements can be harmful to cancer patients and place additional burdens on medical practices, survey results suggest.

Three good practice statements include regularly testing serum iron studies, which can influence decision to use oral or IV iron treatment ...

LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.

Only 19% of patients were treated with oral and/or third-line therapies during six-year study; third-line therapy increased from 2013 to 2018 ...

Researchers identified a tumor cell-specific transcriptomic signature that appeared to be associated with treatment resistance and worse outcomes.

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

(HealthDay News) — President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation’s largest medical ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...